HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences has reported Revenue for 5 years, with the latest figure at $2419.0 in Q4 2025.

• For the quarter ending Q4 2025, Revenue changed N/A year-over-year to $2419.0; the trailing twelve-month figure through Jan 2026 stood at $8669.0 (down 53.39% YoY), and the FY2025 full-year result was $4350.0, down 76.61% from the prior year.
• Revenue for Q4 2025 stood at $2419.0, up from $1900.0 in the prior quarter.
• The five-year high for Revenue was $14700.0 in Q1 2024, with the low at $1900.0 in Q3 2025.
• Historically, Revenue has averaged $4679.2 across 5 years, with a median of $3550.0 in 2022.
• Annual changes were most pronounced in 2022 — Revenue slumped 57.24% — and 2024, when it surged 653.85%.
• HeartSciences' Revenue stood at $7484.0 in 2021, then tumbled by 57.24% to $3200.0 in 2022, then climbed by 21.88% to $3900.0 in 2023, then soared by 276.92% to $14700.0 in 2024, then slumped by 83.54% to $2419.0 in 2025.
• The last three Revenue figures came in at $2419.0 (Q4 2025), $1900.0 (Q3 2025), and $4350.0 (Q2 2025), per Business Quant data.